-
1
-
-
0003037893
-
Assessment and management of mechanical bowel obstruction
-
Portenoy RK, Bruera E (eds) Oxford University Press, New York
-
Mercadante S (1997) Assessment and management of mechanical bowel obstruction. In: Portenoy RK, Bruera E (eds) Topics in palliative care, vol 1. Oxford University Press, New York, pp 113-130
-
(1997)
Topics in Palliative Care
, vol.1
, pp. 113-130
-
-
Mercadante, S.1
-
2
-
-
0027455706
-
Management of bowel obstruction in advanced and terminal cancer patients
-
Ripamonti C, De Conno F, Ventafridda V, Rossi B, Baines MJ (1993) Management of bowel obstruction in advanced and terminal cancer patients. Ann Oncol 4:15-21
-
(1993)
Ann Oncol
, vol.4
, pp. 15-21
-
-
Ripamonti, C.1
De Conno, F.2
Ventafridda, V.3
Rossi, B.4
Baines, M.J.5
-
3
-
-
0022380067
-
Medical management of intestinal obstruction in patients with advanced malignant disease. A clinical and pathological study
-
Baines M, Oliver DJ, Carter RL (1985) Medical management of intestinal obstruction in patients with advanced malignant disease. A clinical and pathological study. Lancet II:990-993
-
(1985)
Lancet
, vol.2
, pp. 990-993
-
-
Baines, M.1
Oliver, D.J.2
Carter, R.L.3
-
4
-
-
0025112860
-
The management of inoperable gastrointestinal obstruction in terminal cancer patients
-
Ventafridda V, Ripamonti C, Caraceni, Spoldi E, Messina E, De Conno F (1990)The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori 76:389-393
-
(1990)
Tumori
, vol.76
, pp. 389-393
-
-
Ventafridda, V.1
Ripamonti, C.2
Caraceni3
Spoldi, E.4
Messina, E.5
De Conno, F.6
-
5
-
-
0027991169
-
The role of octreotide in palliative care
-
Mercadante S (1994) The role of octreotide in palliative care. J Pain Symptom Manage 9:406-411
-
(1994)
J Pain Symptom Manage
, vol.9
, pp. 406-411
-
-
Mercadante, S.1
-
6
-
-
0029298849
-
Bowel obstruction in home care cancer patients
-
Mercadante S (1995) Bowel obstruction in home care cancer patients. Support Care Cancer 3:190-193
-
(1995)
Support Care Cancer
, vol.3
, pp. 190-193
-
-
Mercadante, S.1
-
7
-
-
0028082403
-
Palliation of malignant intestinal obstruction using octreotide
-
Khoo D, Hall E, Motson R, Riley J, Deman K, Waxman J (1994) Palliation of malignant intestinal obstruction using octreotide. Eur J Cancer [A] 30:28-30
-
(1994)
Eur J Cancer [A]
, vol.30
, pp. 28-30
-
-
Khoo, D.1
Hall, E.2
Motson, R.3
Riley, J.4
Deman, K.5
Waxman, J.6
-
8
-
-
0026951026
-
Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients
-
Mercadante S, Maddaloni S (1992) Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients. J Pain Symptom Manage 7:496-498
-
(1992)
J Pain Symptom Manage
, vol.7
, pp. 496-498
-
-
Mercadante, S.1
Maddaloni, S.2
-
9
-
-
0027445761
-
Octreotide in relieving gastrointestinal symptoms due to bowel obstruction
-
Mercadante S, Spoldi E, Caraceni A, Maddaloni S, Simonetti MT (1993) Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 7:295-299
-
(1993)
Palliat Med
, vol.7
, pp. 295-299
-
-
Mercadante, S.1
Spoldi, E.2
Caraceni, A.3
Maddaloni, S.4
Simonetti, M.T.5
-
10
-
-
0029996754
-
Octreotide in the management of bowel obstruction in terminal ovarian cancer
-
Mangili G, Franchi M, Mariani A, Zanaboni F, Rabaiotti E, Frigerio L, et al (1996) Octreotide in the management of bowel obstruction in terminal ovarian cancer. Gynecol Oncol 61:345-348
-
(1996)
Gynecol Oncol
, vol.61
, pp. 345-348
-
-
Mangili, G.1
Franchi, M.2
Mariani, A.3
Zanaboni, F.4
Rabaiotti, E.5
Frigerio, L.6
-
11
-
-
0025721959
-
Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction
-
De Conno F, Caraceni A, Zecca E, Spoldi E, Ventafridda V (1991) Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. J Pain Symptom Manage 6:484-486
-
(1991)
J Pain Symptom Manage
, vol.6
, pp. 484-486
-
-
De Conno, F.1
Caraceni, A.2
Zecca, E.3
Spoldi, E.4
Ventafridda, V.5
-
12
-
-
0027378872
-
Inflammation as a major cause of fluid losses in small-bowel obstruction
-
Nellgard P, Cassuto J (1993) Inflammation as a major cause of fluid losses in small-bowel obstruction. Scand J Gastroenterol 28:1035-1041
-
(1993)
Scand J Gastroenterol
, vol.28
, pp. 1035-1041
-
-
Nellgard, P.1
Cassuto, J.2
-
13
-
-
0029047645
-
Importance of vasoactive intestinal peptide and somatostatin for fluid losses in small-bowel obstruction
-
Nellgard P, Bojo L, Cassuto J (1995) Importance of vasoactive intestinal peptide and somatostatin for fluid losses in small-bowel obstruction. Scand J Gastroenterol 30:464-469
-
(1995)
Scand J Gastroenterol
, vol.30
, pp. 464-469
-
-
Nellgard, P.1
Bojo, L.2
Cassuto, J.3
-
14
-
-
0029993633
-
Small-bowel obstruction and the effects of lidocaine, atropine and hexamethonium on inflammation and fluid losses
-
Nellgard P, Jonsson A, Bojo L, Tarnow P, Cassuto J (1996) Small-bowel obstruction and the effects of lidocaine, atropine and hexamethonium on inflammation and fluid losses. Acta Anaesthesiol Scand 40:287-292
-
(1996)
Acta Anaesthesiol Scand
, vol.40
, pp. 287-292
-
-
Nellgard, P.1
Jonsson, A.2
Bojo, L.3
Tarnow, P.4
Cassuto, J.5
-
15
-
-
0030900840
-
The role of total parenteral nutrition for patients with irreversible bowel obstruction secondary to gynecological malignancy
-
Philip J, Depezynski B (1997) The role of total parenteral nutrition for patients with irreversible bowel obstruction secondary to gynecological malignancy. J Pain Symptom Manage 13:104-111
-
(1997)
J Pain Symptom Manage
, vol.13
, pp. 104-111
-
-
Philip, J.1
Depezynski, B.2
|